Michael B. Van Baar - Publications

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Journal: BMJ open

Published: February 26, 2026

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis.

Journal: BMJ open

Published: February 26, 2026

Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 23, 2025

NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease.

Journal: Cell reports

Published: April 24, 2025

Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial.

Journal: Diabetes, obesity & metabolism

Published: January 24, 2025

Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney Function.

Journal: Kidney international reports

Published: September 26, 2022

SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: September 27, 2021

Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity.

Journal: Journal of diabetes and its complications

Published: June 23, 2021

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors.

Journal: Nephrology (Carlton, Vic.)

Published: October 20, 2020

Renoprotection in diabetic kidney disease: can incretin-based therapies deliver?

Journal: Current opinion in nephrology and hypertension

Published: November 13, 2019

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.

Journal: Diabetes care

Published: August 22, 2019

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.

Journal: Diabetes care

Published: August 16, 2019